Optimizing duration of renin–angiotensin system inhibition after ST-elevation myocardial infarction with drug-eluting stent–percutaneous coronary intervention: Real-World Landmark Evidence from the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry

Coronary Artery Disease · Published 2026-02-06 · DOI 10.1097/mca.0000000000001622

Authors being retrieved — see the publisher record. https://doi.org/10.1097/mca.0000000000001622

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles